Short Interest in Roche Holding AG (OTCMKTS:RHHBY) Decreases By 45.0%

Roche Holding AG (OTCMKTS:RHHBY) saw a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 2,068,200 shares, a decline of 45.0% from the January 31st total of 3,761,500 shares. Based on an average daily trading volume, of 2,515,400 shares, the short-interest ratio is currently 0.8 days.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on RHHBY. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Morgan Stanley initiated coverage on shares of Roche in a report on Wednesday, February 12th. They issued an “equal weight” rating for the company. Finally, UBS Group upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Institutional Investors Weigh In On Roche

A number of hedge funds have recently made changes to their positions in RHHBY. Altrius Capital Management Inc increased its holdings in Roche by 0.3% during the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock worth $6,399,000 after buying an additional 603 shares during the last quarter. Kornitzer Capital Management Inc. KS grew its position in shares of Roche by 1.3% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock valued at $5,490,000 after acquiring an additional 1,798 shares during the period. Bard Financial Services Inc. increased its stake in shares of Roche by 37.7% during the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after purchasing an additional 30,350 shares during the last quarter. Diversified Trust Co raised its holdings in shares of Roche by 1.2% in the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after purchasing an additional 711 shares during the period. Finally, Hantz Financial Services Inc. lifted its stake in Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after purchasing an additional 305 shares during the last quarter.

Roche Price Performance

Shares of Roche stock opened at $41.83 on Tuesday. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. The business’s fifty day simple moving average is $38.38 and its 200 day simple moving average is $38.41. Roche has a 12 month low of $29.20 and a 12 month high of $42.43.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.